Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

A segregation analysis of Barrett's esophagus and associated adenocarcinomas.

Sun X, Elston R, Barnholtz-Sloan J, Falk G, Grady WM, Kinnard M, Mittal SK, Willis JE, Markowitz S, Brock W, Chak A.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):666-74. doi: 10.1158/1055-9965.EPI-09-1136. Epub 2010 Mar 3.

2.

Identification of Barrett's esophagus in relatives by endoscopic screening.

Chak A, Faulx A, Kinnard M, Brock W, Willis J, Wiesner GL, Parrado AR, Goddard KA.

Am J Gastroenterol. 2004 Nov;99(11):2107-14.

PMID:
15554988
3.

Familial trends of inheritance in gastro esophageal reflux disease, Barrett's esophagus and Barrett's adenocarcinoma: 20 families.

Sappati Biyyani RS, Chessler L, McCain E, Nelson K, Fahmy N, King J.

Dis Esophagus. 2007;20(1):53-7.

PMID:
17227311
4.

Comparison of endoscopic and clinical characteristics of patients with familial and sporadic Barrett's esophagus.

Ash S, Vaccaro BJ, Dabney MK, Chung WK, Lightdale CJ, Abrams JA.

Dig Dis Sci. 2011 Jun;56(6):1702-6. doi: 10.1007/s10620-011-1620-3. Epub 2011 Feb 24.

5.

Familial Barrett's esophagus associated with adenocarcinoma.

Jochem VJ, Fuerst PA, Fromkes JJ.

Gastroenterology. 1992 Apr;102(4 Pt 1):1400-2.

PMID:
1551547
6.

Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.

Chak A, Ochs-Balcom H, Falk G, Grady WM, Kinnard M, Willis JE, Elston R, Eng C.

Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1668-73.

7.

Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma.

Ochs-Balcom HM, Falk G, Grady WM, Kinnard M, Willis J, Elston R, Eng C, Chak A.

Transl Res. 2007 Jul;150(1):3-17. Epub 2007 May 25. Review.

PMID:
17585859
8.

Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinoma.

Drovdlic CM, Goddard KA, Chak A, Brock W, Chessler L, King JF, Richter J, Falk GW, Johnston DK, Fisher JL, Grady WM, Lemeshow S, Eng C.

J Med Genet. 2003 Sep;40(9):651-6. Erratum in: J Med Genet. 2004 Jan;41(1):46.

9.

Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus.

Chak A, Chen Y, Vengoechea J, Canto MI, Elston R, Falk GW, Grady WM, Guda K, Kinnard M, Markowitz S, Mittal S, Prasad G, Shaheen N, Willis JE, Barnholtz-Sloan JS.

Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):376-83. doi: 10.1158/1055-9965.EPI-11-0927. Epub 2011 Dec 16.

10.

Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults.

Chak A, Lee T, Kinnard MF, Brock W, Faulx A, Willis J, Cooper GS, Sivak MV Jr, Goddard KA.

Gut. 2002 Sep;51(3):323-8.

11.

Barrett's esophagus: an acquired condition with genetic predisposition.

Fahmy N, King JF.

Am J Gastroenterol. 1993 Aug;88(8):1262-5.

PMID:
8338095
12.

Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.

Ferguson HR, Wild CP, Anderson LA, Murphy SJ, Johnston BT, Murray LJ, Watson RG, McGuigan J, Reynolds JV, Hardie LJ.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):727-31. doi: 10.1158/1055-9965.EPI-07-2570.

13.

Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.

Babar M, Ryan AW, Anderson LA, Segurado R, Turner G, Murray LJ, Murphy SJ, Johnston BT, Comber H, Reynolds JV, McManus R.

Am J Gastroenterol. 2012 Sep;107(9):1331-41. doi: 10.1038/ajg.2012.134. Epub 2012 Jun 5.

PMID:
22664470
14.

A family history of Barrett's oesophagus: another risk factor?

Groves C, Jankowski J, Barker F, Holdstock G.

Scand J Gastroenterol. 2005 Sep;40(9):1127-8.

PMID:
16211720
15.

Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.

Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, Burgart LJ, Ahlquist DA.

Int J Cancer. 2005 Sep 10;116(4):584-91.

16.

Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.

Dura P, van Veen EM, Salomon J, te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH.

Int J Cancer. 2013 Oct 1;133(7):1751-5. doi: 10.1002/ijc.28160. Epub 2013 Apr 16.

17.

Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.

Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L, Risch HA, Liu G, Bird NC, Wu AH, Corley DA, Romero Y, Chanock SJ, Chow WH, Casson AG, Levine DM, Zhang R, Ek WE, MacGregor S, Ye W, Hardie LJ, Vaughan TL, Whiteman DC.

J Natl Cancer Inst. 2014 Sep 30;106(11). pii: dju252. doi: 10.1093/jnci/dju252. Print 2014 Nov.

18.
19.

Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk.

Lee E, Stram DO, Ek WE, Onstad LE, MacGregor S, Gharahkhani P, Ye W, Lagergren J, Shaheen NJ, Murray LJ, Hardie LJ, Gammon MD, Chow WH, Risch HA, Corley DA, Levine DM, Whiteman DC, Bernstein L, Bird NC, Vaughan TL, Wu AH.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1801-3. doi: 10.1158/1055-9965.EPI-15-0596. Epub 2015 Sep 12.

20.

Risk factors, DNA damage, and disease progression in Barrett's esophagus.

Olliver JR, Hardie LJ, Gong Y, Dexter S, Chalmers D, Harris KM, Wild CP.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):620-5.

Supplemental Content

Support Center